Cryptococcosis Drugs Market Outlook 2026-2036 [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
conditions, and rising vulnerability to infections like cryptococcosis, leading to steady market growth. Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Cryptococcosis Drugs Market Outlook 2026-2036" report has been added to ResearchAndMarkets.com's offering. The global cryptococcosis drug market is valued at USD 1.23 billion in 2025 and is expected to grow to USD 2.18 billion by 2036, registering a CAGR of 5.39%. In 2026, the industry size of the global cryptococcosis drugs market is expected to be USD 1.29 billion. The growing global aging population is a key driver of the cryptococcosis drug market, as older adults are more susceptible to chronic conditions that weaken the immune system and increase vulnerability to opportunistic infections such as cryptococcosis. Company Market Share, 2036 (%) Business Profile of Key Enterprise Pfizer Inc Bristol Myers Squibb Company Astellas Pharma Inc Glenmark Pharmaceuticals Janssen Biotech Inc Novartis AG Sigmapharm Lab
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer protects $6.4bn heart disease blockbuster from generics, for now [Yahoo! Finance]Yahoo! Finance
- Global Pharmaceutical Market Poised to Surpass USD 3.2 Trillion by 2035 – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Pfizer (PFE) had its "neutral" rating reaffirmed by Citigroup Inc..MarketBeat
- Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple MyelomaBusiness Wire
- 2 High-Yielding Dividend Stocks to Buy for Passive Income in April [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 4/27/26 - Form 4
- 4/27/26 - Form 4
- 4/27/26 - Form 4
- PFE's page on the SEC website